Flora Chang1,2,3, Ann M O'Hare4,5, Yinghui Miao2,3, Michael A Steinman2,3. 1. School of Medicine, University of California at Davis, Davis, California. 2. Division of Geriatrics, University of California San Francisco, San Francisco, California. 3. San Francisco Veterans Affairs Medical Center, San Francisco, California. 4. Division of Nephrology, University of Washington, Seattle, Washington. 5. Seattle Veterans Affairs Medical Center, Seattle, Washington.
Abstract
OBJECTIVES: To determine how many ambulatory older adults with chronic kidney disease receive medications that are contraindicated or dosed excessively given their level of renal function. DESIGN: Cross-sectional retrospective study. SETTING: U.S. Department of Veterans Affairs (VA) clinics. PARTICIPANTS: Individuals aged 65 and older with a creatinine clearance (CrCl) of 15 to 49 mL/min (N = 83,850; mean age 80; 96% male). MEASUREMENTS: Forty medications that require dose adjustment or are contraindicated in people with impaired renal function were examined. Medication use and CrCl (calculated using the Cockroft-Gault equation) were assessed using VA pharmacy, laboratory, and other data sources as of October 2007. RESULTS: Thirteen percent of older veterans with a CrCl of 30 to 49 mL/min and 32% of those with a CrCl of 15 to 29 mL/min received one or more drugs that were contraindicated or prescribed at an excessive dose given the individual's level of renal function. The strongest risk factor for renally inappropriate prescribing was number of medications used; the risk of receiving renally inappropriate medications was 5.5 times as high (95% confidence interval = 5.1-5.9) in older adults taking 10 or more medications as in those taking one to three medications. Ranitidine, allopurinol, and metformin together accounted for 76% of renally misprescribed medications in individuals with a CrCl of 30 to 49 mL/min. Glyburide, ranitidine, gemfibrozil, carvedilol, and allopurinol accounted for 47% of renally misprescribed drugs for individuals with a CrCl of 15 to 29 mL/min. CONCLUSION: Inappropriate prescribing of renally cleared medications is common in ambulatory older veterans, with only a few medications accounting for most of these prescribing problems.
OBJECTIVES: To determine how many ambulatory older adults with chronic kidney disease receive medications that are contraindicated or dosed excessively given their level of renal function. DESIGN: Cross-sectional retrospective study. SETTING: U.S. Department of Veterans Affairs (VA) clinics. PARTICIPANTS: Individuals aged 65 and older with a creatinine clearance (CrCl) of 15 to 49 mL/min (N = 83,850; mean age 80; 96% male). MEASUREMENTS: Forty medications that require dose adjustment or are contraindicated in people with impaired renal function were examined. Medication use and CrCl (calculated using the Cockroft-Gault equation) were assessed using VA pharmacy, laboratory, and other data sources as of October 2007. RESULTS: Thirteen percent of older veterans with a CrCl of 30 to 49 mL/min and 32% of those with a CrCl of 15 to 29 mL/min received one or more drugs that were contraindicated or prescribed at an excessive dose given the individual's level of renal function. The strongest risk factor for renally inappropriate prescribing was number of medications used; the risk of receiving renally inappropriate medications was 5.5 times as high (95% confidence interval = 5.1-5.9) in older adults taking 10 or more medications as in those taking one to three medications. Ranitidine, allopurinol, and metformin together accounted for 76% of renally misprescribed medications in individuals with a CrCl of 30 to 49 mL/min. Glyburide, ranitidine, gemfibrozil, carvedilol, and allopurinol accounted for 47% of renally misprescribed drugs for individuals with a CrCl of 15 to 29 mL/min. CONCLUSION: Inappropriate prescribing of renally cleared medications is common in ambulatory older veterans, with only a few medications accounting for most of these prescribing problems.
Authors: Ali R Rahimi; Klugh Kennedy; Misha Thomason; Jennifer Crumley; Amanda Bugg; Erin Peacock Journal: South Med J Date: 2008-08 Impact factor: 0.954
Authors: Bharati Bhardwaja; Nikki M Carroll; Marsha A Raebel; Elizabeth A Chester; Eli J Korner; Bob E Rocho; David W Brand; David J Magid Journal: Pharmacotherapy Date: 2011-04 Impact factor: 4.705
Authors: Michael A Steinman; Brian C Lund; Yinghui Miao; W John Boscardin; Peter J Kaboli Journal: J Am Geriatr Soc Date: 2011-03-15 Impact factor: 5.562
Authors: Joseph T Hanlon; Xiaoqiang Wang; Steven M Handler; Steven Weisbord; Mary Jo Pugh; Todd Semla; Roslyn A Stone; Sherrie L Aspinall Journal: J Am Med Dir Assoc Date: 2010-10-02 Impact factor: 4.669
Authors: Lesley A Stevens; Thomas D Nolin; Michelle M Richardson; Harold I Feldman; Julia B Lewis; Roger Rodby; Raymond Townsend; Aghogho Okparavero; Yaping Lucy Zhang; Christopher H Schmid; Andrew S Levey Journal: Am J Kidney Dis Date: 2009-05-17 Impact factor: 8.860
Authors: Kevin M Terrell; Anthony J Perkins; Paul R Dexter; Siu L Hui; Christopher M Callahan; Douglas K Miller Journal: J Am Geriatr Soc Date: 2009-06-22 Impact factor: 5.562
Authors: Solène M Laville; Marie Metzger; Bénédicte Stengel; Christian Jacquelinet; Christian Combe; Denis Fouque; Maurice Laville; Luc Frimat; Carole Ayav; Elodie Speyer; Bruce M Robinson; Ziad A Massy; Sophie Liabeuf Journal: Br J Clin Pharmacol Date: 2018-09-24 Impact factor: 4.335
Authors: Justin X G Zhu; Danielle M Nash; Eric McArthur; Alexandra Farag; Amit X Garg; Arsh K Jain Journal: Nephrol Dial Transplant Date: 2019-04-01 Impact factor: 5.992